Williams, B;
MacDonald, TM;
Morant, S;
Webb, DJ;
Sever, P;
McInnes, G;
Ford, I;
... Brown, MJ; + view all
(2015)
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.
Lancet
, 386
(10008)
pp. 2059-2068.
10.1016/S0140-6736(15)00257-3.